An elderly Oklahoma woman stricken with Parkinson’s Disease lost $20,000 in a cryptocurrency ploy that was crafted as a scam ...
Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
GlobalData on MSN22h
DMTs are major clinical research focus for Parkinson’s disease, analysis showsAnalysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...
Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
News Medical on MSN14h
New biomarker could help predict Parkinson’s disease progressionA team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, ...
Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...
Live Science on MSN6d
E. coli in the gut may fuel a 'chain reaction' leading to Parkinson's, early study suggestsTwo recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.
GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...
A new study that aims to understand the genetics of Parkinson’s has been held up by the need for 7000 Australians without a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback